166 related articles for article (PubMed ID: 26671284)
21. Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
Lerouet D; Marchand-Leroux C; Besson VC
Fundam Clin Pharmacol; 2021 Jun; 35(3):524-538. PubMed ID: 33527472
[TBL] [Abstract][Full Text] [Related]
22. Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury.
Boutté AM; Deng-Bryant Y; Johnson D; Tortella FC; Dave JR; Shear DA; Schmid KE
J Neurotrauma; 2016 Jan; 33(1):147-56. PubMed ID: 25789543
[TBL] [Abstract][Full Text] [Related]
23. Melatonin as a Therapy for Traumatic Brain Injury: A Review of Published Evidence.
Osier N; McGreevy E; Pham L; Puccio A; Ren D; Conley YP; Alexander S; Dixon CE
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786658
[TBL] [Abstract][Full Text] [Related]
24. Challenging the Paradigms of Experimental TBI Models: From Preclinical to Clinical Practice.
Tortella FC
Methods Mol Biol; 2016; 1462():735-40. PubMed ID: 27604748
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-κB signaling pathway in experimental traumatic brain injury.
Feng Y; Cui Y; Gao JL; Li MH; Li R; Jiang XH; Tian YX; Wang KJ; Cui CM; Cui JZ
Int J Mol Med; 2016 Apr; 37(4):921-30. PubMed ID: 26936125
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporine as Therapy for Traumatic Brain Injury.
Hansson MJ; Elmér E
Neurotherapeutics; 2023 Oct; 20(6):1482-1495. PubMed ID: 37561274
[TBL] [Abstract][Full Text] [Related]
27. Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury.
Ekici MA; Uysal O; Cikriklar HI; Özbek Z; Turgut Cosan D; Baydemir C; Kazanci B; Hafizoğlu D
Eur Rev Med Pharmacol Sci; 2014; 18(1):10-27. PubMed ID: 24452937
[TBL] [Abstract][Full Text] [Related]
28. Therapies negating neuroinflammation after brain trauma.
Hellewell S; Semple BD; Morganti-Kossmann MC
Brain Res; 2016 Jun; 1640(Pt A):36-56. PubMed ID: 26740405
[TBL] [Abstract][Full Text] [Related]
29. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310
[TBL] [Abstract][Full Text] [Related]
30. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.
Besson VC; Chen XR; Plotkine M; Marchand-Verrecchia C
Neurosci Lett; 2005 Nov; 388(1):7-12. PubMed ID: 16087294
[TBL] [Abstract][Full Text] [Related]
31. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
[TBL] [Abstract][Full Text] [Related]
32. Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury.
Statler KD; Alexander H; Vagni V; Holubkov R; Dixon CE; Clark RS; Jenkins L; Kochanek PM
Brain Res; 2006 Mar; 1076(1):216-24. PubMed ID: 16473332
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotection and anti-seizure effects of levetiracetam in a rat model of penetrating ballistic-like brain injury.
Caudle KL; Lu XC; Mountney A; Shear DA; Tortella FC
Restor Neurol Neurosci; 2016; 34(2):257-70. PubMed ID: 26890099
[TBL] [Abstract][Full Text] [Related]
34. Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats.
Belayev L; Alonso OF; Huh PW; Zhao W; Busto R; Ginsberg MD
J Neurotrauma; 1999 Jun; 16(6):445-53. PubMed ID: 10391362
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
[TBL] [Abstract][Full Text] [Related]
36. Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?
Kline AE; Leary JB; Radabaugh HL; Cheng JP; Bondi CO
Prog Neurobiol; 2016 Jul; 142():45-67. PubMed ID: 27166858
[TBL] [Abstract][Full Text] [Related]
37. A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury.
Lulic D; Burns J; Bae EC; van Loveren H; Borlongan CV
Neurosurgery; 2011 May; 68(5):1172-85; discussion 1185-6. PubMed ID: 21307793
[TBL] [Abstract][Full Text] [Related]
38. Enduring Neuroprotective Effect of Subacute Neural Stem Cell Transplantation After Penetrating TBI.
Kassi AAY; Mahavadi AK; Clavijo A; Caliz D; Lee SW; Ahmed AI; Yokobori S; Hu Z; Spurlock MS; Wasserman JM; Rivera KN; Nodal S; Powell HR; Di L; Torres R; Leung LY; Rubiano AM; Bullock RM; Gajavelli S
Front Neurol; 2018; 9():1097. PubMed ID: 30719019
[TBL] [Abstract][Full Text] [Related]
39. Catecholaminergic based therapies for functional recovery after TBI.
Osier ND; Dixon CE
Brain Res; 2016 Jun; 1640(Pt A):15-35. PubMed ID: 26711850
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of ebselen in traumatic brain injury model: involvement of nitric oxide and p38 mitogen-activated protein kinase signalling pathway.
Wei L; Zhang Y; Yang C; Wang Q; Zhuang Z; Sun Z
Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):134-8. PubMed ID: 24131109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
